Ribose (Furanose)

Ribose (Furanose)

SCHEMBL7051560

OC[C@H]1OC(O)[C@@H](O)[C@@H]1O.c1cncnc1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.41
CDA P32320 1/20 0.41
LGALS1 P09382 2/20 0.39
LGALS3 P17931 2/20 0.39
LGALS9 O00182 1/20 0.39
LGALS8 O00214 1/20 0.39
OGA O60502 1/20 0.38
HEXA P06865 1/20 0.38
HEXB P07686 1/20 0.38
ADA P00813 1/20 0.37
TYR P14679 1/20 0.37
HK1 P19367 1/20 0.36
HK2 P52789 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ribose (Furanose) SCHEMBL10818882 1.00 MAPT (0.41) MAPTCDALGALS1LGALS3LGALS9
Ribose (Furanose) SCHEMBL3655770 1.00 MAPT (0.41) MAPTCDALGALS1LGALS3LGALS9
Ribose (Furanose) SCHEMBL7511471 1.00 MAPT (0.41) MAPTCDALGALS1LGALS3LGALS9
Ribose (Furanose) SCHEMBL18788526 0.88 MAPT (0.41) MAPTCDALGALS1LGALS3LGALS9
Dextrose SCHEMBL28143229 0.81 LGALS1 (0.52) LGALS1LGALS3LGALS9LGALS8HK1
B-D-Galactose SCHEMBL27766291 0.81 LGALS1 (0.52) LGALS1LGALS3LGALS9LGALS8HK1
Beta-D-Glucose SCHEMBL27745359 0.81 LGALS1 (0.52) LGALS1LGALS3LGALS9LGALS8HK1
B-D-Galactose SCHEMBL28251165 0.81 LGALS1 (0.52) LGALS1LGALS3LGALS9LGALS8HK1
Ribose (Furanose) SCHEMBL23017520 0.80 LGALS1 (0.54) LGALS1LGALS3LGALS9LGALS8
Ribose (Furanose) SCHEMBL77096 0.80 LGALS1 (0.54) LGALS1LGALS3LGALS9LGALS8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0415731-B1 Novel entities for cancer therapy WELLCOME FOUND (GB) 2003-04-02 EP claimed
EP-0690129-A1 Novel entities for cancer therapy THE WELLCOME FOUNDATION LIMITED (GB) 1996-01-03 EP claimed
EP-0657539-A1 Novel entities for cancer therapy THE WELLCOME FOUNDATION LIMITED (GB) 1995-06-14 EP claimed
EP-0657541-A1 Novel entities for cancer therapy THE WELLCOME FOUNDATION LIMITED (GB) 1995-06-14 EP claimed
EP-0657540-A1 Novel entities for cancer therapy THE WELLCOME FOUNDATION LIMITED (GB) 1995-06-14 EP claimed
JP-57118797-A None JP disclosed
JP-55045625-A None JP disclosed
JP-55037167-A None JP disclosed
JP-55013010-A None JP disclosed
JP-55104894-A None JP disclosed
CN-114920840-A Antibody molecules against PD-L1 and uses thereof 诺华股份有限公司 2022-08-19 CN disclosed
CN-112410363-A anti-CD 123 Chimeric Antigen Receptor (CAR) for cancer therapy 诺华股份有限公司 2021-02-26 CN disclosed
JP-S55104894-A PRODUCTION OF PYRIMIDINE-ARABINOSIDES AJINOMOTO CO INC 1980-08-11 JP disclosed
JP-S5545625-A 2-METHYL-N6-SUBSTITUTED ADENINE-ARABINOSIDE AND ITS PREPARATION AJINOMOTO CO INC 1980-03-31 JP disclosed
JP-S5537167-A PRODUCTION OF PURINE ARABINOSIDE AJINOMOTO CO INC 1980-03-15 JP disclosed
JP-S5513010-A PREPARATION OF PURINE ARABINOSIDE AJINOMOTO CO INC 1980-01-29 JP disclosed
EP-0002192-A1 Enzymatic synthesis of purine arabinonucleosides THE WELLCOME FOUNDATION LIMITED (GB) 1979-06-13 EP disclosed
JP-S05537167-A 0001-01-01 JP disclosed
JP-S05545625-A 0001-01-01 JP disclosed
JP-S05513010-A 0001-01-01 JP disclosed